Catalyst N° 035 of 125 12 Sep 2024
The better mousetrap fallacy
with Andy Lubershane, partner and head of research, Energy Impact Partners
In this note
The question
Which parts of climate tech still need a technology breakthrough, and which ones only need someone to build a lot more of what already works?
The answer
It depends on whether the incumbent technology is still descending a scale-driven cost curve. Where it is, a challenger has to be five or ten times better rather than twenty or fifty percent better, because the incumbent will pass anything closer while the challenger is still commercializing. Lubershane applies that test confidently to grid and mobility storage and to nuclear fission, tentatively to direct air capture, and he argues the real cost of too many options is not wasted venture capital but buyers who cannot choose. Kann sharpens the storage and nuclear cases but opens the episode saying he is not so sure of the thesis overall, and he breaks with Lubershane on direct air capture.
03The argument
The better mousetrap fallacy, as Lubershane defines it, is the assumption that some new invention is the thing that will unlock a market, applied to a market where invention is not what is missing. He is careful about the boundary, and the care is the point. He refuses to re-run the old innovation-versus-deployment argument, says this is plainly a both-and, and insists there are many problems on the route to net zero where we do not have anything close to the right technology and need not just better mousetraps but entirely different kinds of trap. His narrower worry has two parts, and he says explicitly that he is not much troubled by the first: venture investors putting money into new technology can look after themselves. What bothers him is the second, that a proliferation of options is close to paralyzing for the people who would otherwise deploy. Working with utilities and large energy infrastructure operators, he sees analysis paralysis among buyers weighing novel storage, unable to pick a lane and get comfortable with it because there are so many on offer.
The mechanism behind that judgment comes from solar. By the 2000s and 2010s the winner was already the incumbent, crystalline silicon, and the enormous cost decline that followed came from scaling it over and over rather than from any of the hundred or so startups then pursuing thin film, cadmium telluride, amorphous silicon and other cells. Lithium-ion repeated the pattern. Innovation did not stop, but it moved inside the scaling: Lubershane estimates that 95% of the time the improvement is a tweak or iteration on the existing formula rather than a new chemistry, and every new factory teaches the industry something. China is extremely good at exactly this kind of incrementalism, which he offers as part of the reason the world became dependent on it, while the American taste for novelty, boldness and restlessness is a genuine strength that becomes a blind spot when the task is scaling. That produces the threshold. Kann puts it first, saying that 20% better than the incumbent is not better enough because the industry will pass you within five or ten years, so a challenger has to be five or ten times better; Lubershane agrees and adds the harder part, which is that when the incumbent’s improvement is happening mostly inside Chinese factories you cannot see clearly how fast its cost is falling even two or three years out. To bet against a curve you cannot observe, the bet has to be enormous.
Storage is where he draws the line, and where he says the fallacy has taken hold: for more than a decade a near-continuous stream of approaches in the 20% to 50% better-than-lithium-ion range has been crushed, repeatedly. The test he applies is not whether a technology is ahead today but whether it sits outside anything lithium-ion could plausibly reach. Form Energy’s multi-day system qualifies in his view because its target cost is beyond any reasonable vision of lithium-ion’s future, which makes it a different product rather than a competitor, and Rondo’s thermal storage qualifies by doing something electrochemical storage cannot do at all. Both are his own firm’s investments, and both cost claims are targets for products still commercializing. Sodium-ion is the case he explicitly cannot place: a real deviation from lithium-ion, but a close cousin in manufacturing and principle, and already being scaled by the same large battery manufacturers, so it is a better mousetrap of a kind startups are poorly positioned to build. Lithium iron phosphate he treats as plainly incremental. Nuclear is his canonical example, and there the argument is not about atoms at all. Reactors built from the late 1950s through the 1970s, before computer modeling and modern engineering tools, are running well today, and nuclear is still deployed cost-effectively in Korea and China. On that reading the problem was always public opinion, regulation and policy, so incremental Gen 3+ designs are all that is needed, while dozens of developers pursue clever new coolants and passive safety features. Kann sharpens it into the learning curve: the first plants will be expensive whatever the technology, so if a suddenly permissive regulator licensed twenty designs and one of each got built, nobody descends a curve at all. Lubershane’s hypothetical is to pick one to three designs and build ten of each, spaced a year to eighteen months apart, which he says would beat the vast majority of next-generation designs on cost. He catches himself mid-claim there, having first said it would beat any of them, and softens it. He is also sympathetic to the safety pitch in principle, since inherent safety means less redundant protective equipment and therefore a cheaper plant, but suspects it is a red herring, because arguing that today’s fleet is insufficiently safe is both untrue and bad for the industry. What he does not say is that Gen 4 research should stop. His claim is about where commercialization capital and government policy should go.
Direct air capture is where his own confidence drops and where Kann breaks with him. Lubershane raises it saying he does not know whether they will agree or how much he believes it himself. There are over 150 direct air capture startups on a list he considers credible, so there is no shortage of traps; the shortage is mice, meaning buyers willing to pay what the technology costs. Essentially one large buyer, Microsoft, plus a long tail. So the race may be ten years early, though he allows that a decade spent proving out a few is not necessarily wasted. Kann concedes two of the three points: there are probably more carbon removal startups than buyers at meaningful scale, and since almost none have built anything, buyers are forward-contracting on promises and have to guess what is real. But he disagrees on the conclusion, because nobody yet knows whether any approach gets cheap enough, and he wants a lower benchmark than the customary hundred dollars a ton. So he wants more mousetraps in direct air capture, not fewer, even expecting a painful shakeout, and Lubershane accepts the point. That leaves the question of who does the sorting, which neither answers cleanly, and a market force that may do it for them: both think the end of a fifteen-year era of near-zero interest rates will filter ideas earlier. Lubershane calls that a net positive at this stage, conditional on the surviving capital going to areas where no incumbent exists to be incrementally improved. Kann notes it cuts both ways, because earlier filtering also means fewer shots on goal at the biggest problems.
04What you need to know first
- Learning curve, or economies of scale
- The observed pattern where the cost of a manufactured technology falls as cumulative production rises. The driver is repetition of the same thing, which is why building one each of twenty designs does not produce it.
- Gen 3+ versus Gen 4 reactors
- Gen 3+ are incremental improvements on the light water reactors already built and licensed. Gen 4 covers fundamentally different designs using different coolants and passive safety approaches. The episode’s nuclear argument is entirely about which of the two deserves commercialization money.
- Lithium iron phosphate and sodium-ion
- Lithium iron phosphate is a lithium-ion chemistry that trades energy density for lower cost and better safety. Sodium-ion substitutes a different, cheaper atom but is manufactured in a broadly similar way. Lubershane treats the first as plainly incremental; where the second sits is the one question the two speakers cannot settle.
- Forward-contracted carbon removal credits
- Buyers today are purchasing tons from plants that do not exist yet, which is why the ability to judge which developers are real is itself a market function.
05Details worth keeping
- Rondo’s thermal storage works by absorbing electricity, holding it as heat and dispatching heat continuously for industrial processes. The efficiency argument is that converting energy to heat is normally how energy is lost, so a system whose output is heat avoids the electrochemical losses a battery incurs.
- Kann frames the backdrop as the old and annoying fight between the innovation camp (canonically Bill Gates) and the deployment camp (canonically Jigar Shah), and both speakers refuse to be placed in either. Lubershane says that on nuclear specifically he is on the deploy train, and jokes that Shah is its conductor.
- On sorting institutions: Frontier, the Stripe-founded collective buying pool, both aggregates demand and staffs scientists to sift applications, which Kann considers a genuine market function. Microsoft runs a strong internal team for the same reason. The precedent both cite is early corporate renewable power purchasing, where Google, Microsoft and Facebook built in-house teams and intermediaries such as LevelTen later emerged to serve less-resourced buyers.
- The episode’s closing joke carries the thesis: asked about literal mousetraps, Lubershane says actual mousetrap technology has not improved in living memory, and the genuine ten-times solution he found for his own basement was gap filler to seal the holes. The better mousetrap is not having mice.
06Claims worth citing
All figures as stated on 2024-09-12. Startup counts and buyer counts in carbon removal move quickly, and the interest-rate framing is tied to that moment.
- A challenger 20% better than the incumbent will be overtaken within five to ten years; the bar is five to ten times better. Kann, agreed by Lubershane
- For more than a decade, storage challengers claiming 20% to 50% theoretical improvement over lithium-ion have been repeatedly crushed. Lubershane
- Roughly 95% of lithium-ion improvement is a tweak or iteration on the existing formula rather than a new battery technology. Lubershane
- Over 150 direct air capture startups, from a list Lubershane describes as credible but does not name. Lubershane
- There are probably more carbon removal startups than carbon removal buyers at meaningful scale, offered as a favorite statistic with the caveat that it depends how you define it. Kann
- The number of direct air capture companies that have built something with output measurable in tons per year would fit on two hands. Kann
- Microsoft is the single largest carbon removal buyer, by what Lubershane thinks is a considerable margin, and essentially the only large one. Lubershane
- $100 per ton is the common benchmark for durable, permanent, verifiable carbon removal; Kann argues the long-term benchmark should be lower, naming $50 as his own preference. Kann
- Frontier’s committed pool described as a billion dollars plus over eight years, stated loosely. Kann
- Nuclear plants built from the late 1950s into the 1970s, before computer modeling, operate well today, and nuclear is still deployed cost-effectively in Korea and China. Lubershane
- The hypothetical alternative to a proliferation of designs: one to three designs, ten units of each, spaced twelve to eighteen months apart. Lubershane
- Zero interest rate policy ran for roughly fifteen years and was a driver of better-mousetrap funding across tech, not just climate. Lubershane
07Where it’s contested
- Direct air capture is an open disagreement, and the guest hedges his own case. Lubershane introduces it saying he does not know whether they will agree or how much he believes it himself. Kann agrees that startups outnumber buyers and that forward contracting on unbuilt plants is hard for buyers, but argues nobody yet knows whether any approach can get cheap enough, so he wants more options rather than fewer. Lubershane accepts that.
- Sodium-ion is unresolved between them. Lubershane calls it borderline and says “I guess it is a better mousetrap,” while distinguishing it from a startup opportunity because incumbent manufacturers are already scaling it. Kann allows it could turn out to be nothing.
- Lubershane softens his own nuclear claim mid-sentence. He first says a serial build of proven designs would beat any next-generation design on cost, then explicitly withdraws “any” in favor of “the vast majority.”
- The title pulls harder than the guest does. He states repeatedly that there are areas needing genuinely new technology, that he does not want society to stop investing in Gen 4 nuclear, and that his claim concerns commercialization and government policy rather than research. A note that reads this episode as an argument against innovation has inverted it.
- The nuclear licensing point is garbled in the transcript. Lubershane says the regulator should become more efficient and less costly “for licensing as opposed to for licensing technology.” The apparent distinction is between licensing plants to be built and licensing new designs, but the sentence does not parse cleanly and should not be quoted.
- The safety argument is a judgment about perception, not engineering. He is sympathetic that inherent safety features reduce cost, but suspects the safety pitch is a red herring, since it concedes a premise about the existing fleet he considers false.
- Disclosure, narrowly. The test for what escapes the fallacy is illustrated with two of the speakers’ own portfolio companies, disclosed on air. Their cost advantages are stated as design targets for products still being commercialized, so attribute them to the companies rather than treating them as measured results.